GlassScriptPhysician profile
Lisa J Buford
NPI 1780600932
$9,041.32
in general payments reported to CMS, 2019-2025
49 companies · $815 in 2025
The $815 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $943 · 2022: $2,146 · 2023: $2,950 · 2024: $2,187 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,469 · Travel and Lodging: $1,279 · Education: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,469.24 |
| Travel and Lodging | $1,278.79 |
| Education | $204.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,303.17 | 2023-2025 | Inspire |
| Abbvie INC. | $1,290.99 | 2021-2025 | |
| Pfizer INC. | $519.94 | 2021-2025 | |
| Emd Serono, INC. | $510.16 | 2021-2023 | Mavenclad |
| Biohaven Pharmaceutical Holding Company LTD. | $404.63 | 2022 | |
| Novartis Pharmaceuticals Corporation | $350.98 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $349.50 | 2021-2023 | Soliris, Ultomiris |
| Neurocrine Biosciences, INC. | $236.90 | 2021-2023 | Ingrezza, Ongentys |
| Jazz Pharmaceuticals INC. | $215.03 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $183.53 | 2023 | Austedo Xr, Austedo |
| Avanir Pharmaceuticals, INC. | $157.26 | 2021-2022 | |
| Lundbeck LLC | $150.85 | 2021-2023 | Vyepti |
| Idorsia Pharmaceuticals US INC | $148.20 | 2023 | Quviviq |
| Eisai INC. | $143.17 | 2023-2025 | |
| Lilly USA, LLC | $142.07 | 2021-2023 | Amyvid, Emgality, Reyvow |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Buford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.